The US Army is wrapping up early clinical trials on a vaccine it hopes will target all existing coronavirus variants.Named SpFN, for Spike Ferritin Nanoparticle, it has shown promise in non-human primate trials and early human trial results are expected “this month,” according to a press release from the US Army Walter Reed Army Institute of Research released Thursday.The jab could also help protect against other coronaviruses beyond Covid-19, which could offer hope against future pandemics.The…
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Covid-19 News Click Here